Cboe Global Markets Reports Strong Q1 Earnings and Revenue Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 19 2024
0mins
Cboe Global Markets Inc. saw its stock rise by 3.07% as it reached a 52-week high, reflecting strong investor confidence following its recent earnings report.
The company reported a record net revenue of $729 million for Q1 2026, a 29% year-over-year increase, and an adjusted EPS of $3.70, exceeding analysts' estimates by $0.33. Additionally, Cboe raised its 2026 organic total net revenue growth forecast to the low double-digit to mid-teens range, indicating a proactive strategy in enhancing market competitiveness. The announcement of a 20% workforce reduction aims to optimize operational efficiency, further boosting investor optimism.
These strong financial results and strategic moves position Cboe favorably in the market, suggesting continued growth and profitability in the coming quarters.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CBOE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CBOE
Wall Street analysts forecast CBOE stock price to rise
8 Analyst Rating
2 Buy
5 Hold
1 Sell
Hold
Current: 254.690
Low
240.00
Averages
290.86
High
317.00
Current: 254.690
Low
240.00
Averages
290.86
High
317.00
About CBOE
Cboe Global Markets, Inc. is a derivatives and securities exchange network delivering trading, clearing, and investment solutions. The Company provides trading solutions and products in equities, derivatives, and foreign exchange (FX). Its segments include Options, North American Equities, Europe and Asia Pacific, Futures, and Global FX. The Options segment includes options on market indices, as well as on the stocks of individual corporations and on exchange-traded products (ETPs) such as exchange-traded funds (ETFs) and exchange-traded notes (ETNs), which are multi-listed options and listed on a non-exclusive basis. The North American Equities segment includes United States equities and ETP transaction services that occur on fully electronic exchanges. The Europe and Asia Pacific segment includes derivatives transaction services, ETPs, including exchange-traded funds, exchange-traded notes, exchange-traded commodities, and international depository receipts.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Charles Schwab Launches New Yes-or-No Options Linked to S&P 500
- New Options Product Launch: Charles Schwab (SCHW) is partnering with Cboe Global Markets (CBOE) to introduce yes-or-no options linked to the S&P 500 index (SP500), expected to launch in the coming months, aiming to attract more investors to the market.
- Innovative Payout Mechanism: The new offerings will feature Cboe's 'plus zone,' allowing traders to receive partial payouts based on how close they are to the target, enhancing trading flexibility and potentially attracting clients with risk management needs.
- Market Competition Analysis: While Schwab's options differ from prediction market futures offered by Kalshi and Polymarket, their binary options operate similarly, providing predetermined cash payouts if clients exceed the index's closing price, thereby strengthening their position in the competitive financial derivatives market.
- Focus on Financial Events: Charles Schwab intends to concentrate on events within the financial sector, having considered contracts linked to other indexes or benchmarks but excluding next year's Super Bowl winners, a strategic choice that will bolster its brand image among professional investors.
See More
Onco-Innovations Plans CAD 5 Million Private Placement
- Funding Size: Onco-Innovations intends to issue 6,764,069 units at CAD$0.7392 each, aiming for approximately CAD 5 million in total proceeds to support the ONC010 program and advance its clinical development pathway.
- Subscription Condition: The private placement requires subscriptions for at least 6,764,069 units; if the minimum is not met, all funds will be returned to subscribers in accordance with applicable securities laws, ensuring investor capital protection.
- Warrant Terms: Each unit includes a warrant allowing holders to purchase one share at CAD$0.90 within three years, with an option for the company to accelerate the expiry if the 10-day volume-weighted average price reaches CAD$1.30, enhancing potential returns for investors.
- Use of Proceeds: The net proceeds will be allocated to key stages of the ONC010 program, including manufacturing and preclinical testing, as well as general working capital, demonstrating the company's commitment to ongoing R&D investment and strategic planning.
See More
CME Group Shares Decline Nearly 20% Amid Market Concerns
- Stock Price Decline: CME Group's shares have fallen 19.8% over the past three months, nearing a 52-week low of $244.56, reflecting market concerns over its premium valuation and competitive threats, while investors locked in gains after a strong rally earlier this year.
- Optimistic Earnings Outlook: Based on short-term price targets from 15 analysts, the average target price for CME is $308.80, suggesting a potential upside of 22.3% from the last closing price, indicating market confidence in its future profitability.
- Product Expansion Strategy: CME Group recently launched four new E-mini contracts aimed at broadening its benchmark suite of equity index futures to address growing demand for market risk management tools, further solidifying its position in the equity index ecosystem.
- Strong Capital Returns: As of March 31, 2026, CME Group held $2.6 billion in cash and returned approximately $3.2 billion to shareholders through dividends and share repurchases in Q1 2026, demonstrating its robust financial position and ability to attract income-focused investors.
See More
Apple Price Hike and New Highs for Major Banks
- Apple Price Increase: Apple plans to raise product prices due to rising memory chip costs, and while its stock has risen 16% over the past three months, it is currently down 7% from earlier this month, which may impact consumer demand and market share.
- Moderna Vaccine Progress: Moderna is making its case for the mRNA flu vaccine before the FDA committee, with shares up 11.6% on Wednesday and nearly 24% over three days, indicating strong market confidence in its product.
- New Highs for Major Banks: Bank of America, Citigroup, Goldman Sachs, JPMorgan, and Morgan Stanley reached new highs on Wednesday, with Bank of America up 9.5% in June, reflecting investor optimism in the financial sector.
- Oil Price Decline: Brent crude oil fell below its 200-day moving average for the first time since February, down over 27% in the past month, which puts pressure on energy stocks and may affect the earnings outlook for related companies.
See More
SpaceX IPO Sparks Strong Market Demand for Tech Giants
- Strong Market Demand: Following a historic $2 trillion IPO, SpaceX's stock surged 20% on Monday, indicating robust appetite in the U.S. equity market for another tech giant, potentially attracting more investors to high-growth tech companies.
- Options Market Dynamics: The options market will reveal investor sentiment towards SpaceX on Tuesday, with expectations about its future performance influencing stock price volatility, especially amid the recent surge in AI and semiconductor stocks.
- Profitability Challenges: Despite SpaceX's valuation exceeding $1 trillion, it reported a net loss of $4.28 billion in the latest quarter, making it the only publicly traded stock over $1 trillion that remains unprofitable, which may affect investor confidence.
- Impact of Zero-Commission Trading: Robinhood's zero-commission trading model is seen as a key factor in Elon Musk's wealth growth, enabling more retail investors to engage in high-risk investments, further propelling SpaceX's market performance.
See More
SpaceX IPO Boosts Blockchain Exchanges
- Surge in Futures Trading: Ahead of SpaceX's IPO, Hyperliquid saw over 7 million perpetual futures traded, with a volume exceeding $1.2 billion, indicating strong market demand for emerging asset classes and further promoting blockchain technology adoption.
- Strong Market Performance: SpaceX closed its debut trading day at $160.95, achieving a market capitalization of over $2.1 trillion, reflecting robust investor confidence and providing a solid market validation for blockchain exchanges.
- Increased Pressure on Traditional Finance: With Kalshi's approval to trade bitcoin perps, traditional exchanges like CME and Nasdaq face pressure to adapt to rapidly evolving investment products and asset classes to maintain market competitiveness.
- Recognition of Blockchain Technology: Hyperliquid's tradeable token has surged over 150% this year, indicating the growing prominence of blockchain in mainstream finance, serving as a powerful tool against traditional finance and driving the long-term development of digital assets.
See More
Charles Schwab Launches New Yes-or-No Options Linked to S&P 500
- New Options Product Launch: Charles Schwab (SCHW) is partnering with Cboe Global Markets (CBOE) to introduce yes-or-no options linked to the S&P 500 index (SP500), expected to launch in the coming months, aiming to attract more investors to the market.
- Innovative Payout Mechanism: The new offerings will feature Cboe's 'plus zone,' allowing traders to receive partial payouts based on how close they are to the target, enhancing trading flexibility and potentially attracting clients with risk management needs.
- Market Competition Analysis: While Schwab's options differ from prediction market futures offered by Kalshi and Polymarket, their binary options operate similarly, providing predetermined cash payouts if clients exceed the index's closing price, thereby strengthening their position in the competitive financial derivatives market.
- Focus on Financial Events: Charles Schwab intends to concentrate on events within the financial sector, having considered contracts linked to other indexes or benchmarks but excluding next year's Super Bowl winners, a strategic choice that will bolster its brand image among professional investors.
See More
Onco-Innovations Plans CAD 5 Million Private Placement
- Funding Size: Onco-Innovations intends to issue 6,764,069 units at CAD$0.7392 each, aiming for approximately CAD 5 million in total proceeds to support the ONC010 program and advance its clinical development pathway.
- Subscription Condition: The private placement requires subscriptions for at least 6,764,069 units; if the minimum is not met, all funds will be returned to subscribers in accordance with applicable securities laws, ensuring investor capital protection.
- Warrant Terms: Each unit includes a warrant allowing holders to purchase one share at CAD$0.90 within three years, with an option for the company to accelerate the expiry if the 10-day volume-weighted average price reaches CAD$1.30, enhancing potential returns for investors.
- Use of Proceeds: The net proceeds will be allocated to key stages of the ONC010 program, including manufacturing and preclinical testing, as well as general working capital, demonstrating the company's commitment to ongoing R&D investment and strategic planning.
See More
CME Group Shares Decline Nearly 20% Amid Market Concerns
- Stock Price Decline: CME Group's shares have fallen 19.8% over the past three months, nearing a 52-week low of $244.56, reflecting market concerns over its premium valuation and competitive threats, while investors locked in gains after a strong rally earlier this year.
- Optimistic Earnings Outlook: Based on short-term price targets from 15 analysts, the average target price for CME is $308.80, suggesting a potential upside of 22.3% from the last closing price, indicating market confidence in its future profitability.
- Product Expansion Strategy: CME Group recently launched four new E-mini contracts aimed at broadening its benchmark suite of equity index futures to address growing demand for market risk management tools, further solidifying its position in the equity index ecosystem.
- Strong Capital Returns: As of March 31, 2026, CME Group held $2.6 billion in cash and returned approximately $3.2 billion to shareholders through dividends and share repurchases in Q1 2026, demonstrating its robust financial position and ability to attract income-focused investors.
See More
Apple Price Hike and New Highs for Major Banks
- Apple Price Increase: Apple plans to raise product prices due to rising memory chip costs, and while its stock has risen 16% over the past three months, it is currently down 7% from earlier this month, which may impact consumer demand and market share.
- Moderna Vaccine Progress: Moderna is making its case for the mRNA flu vaccine before the FDA committee, with shares up 11.6% on Wednesday and nearly 24% over three days, indicating strong market confidence in its product.
- New Highs for Major Banks: Bank of America, Citigroup, Goldman Sachs, JPMorgan, and Morgan Stanley reached new highs on Wednesday, with Bank of America up 9.5% in June, reflecting investor optimism in the financial sector.
- Oil Price Decline: Brent crude oil fell below its 200-day moving average for the first time since February, down over 27% in the past month, which puts pressure on energy stocks and may affect the earnings outlook for related companies.
See More
SpaceX IPO Sparks Strong Market Demand for Tech Giants
- Strong Market Demand: Following a historic $2 trillion IPO, SpaceX's stock surged 20% on Monday, indicating robust appetite in the U.S. equity market for another tech giant, potentially attracting more investors to high-growth tech companies.
- Options Market Dynamics: The options market will reveal investor sentiment towards SpaceX on Tuesday, with expectations about its future performance influencing stock price volatility, especially amid the recent surge in AI and semiconductor stocks.
- Profitability Challenges: Despite SpaceX's valuation exceeding $1 trillion, it reported a net loss of $4.28 billion in the latest quarter, making it the only publicly traded stock over $1 trillion that remains unprofitable, which may affect investor confidence.
- Impact of Zero-Commission Trading: Robinhood's zero-commission trading model is seen as a key factor in Elon Musk's wealth growth, enabling more retail investors to engage in high-risk investments, further propelling SpaceX's market performance.
See More
SpaceX IPO Boosts Blockchain Exchanges
- Surge in Futures Trading: Ahead of SpaceX's IPO, Hyperliquid saw over 7 million perpetual futures traded, with a volume exceeding $1.2 billion, indicating strong market demand for emerging asset classes and further promoting blockchain technology adoption.
- Strong Market Performance: SpaceX closed its debut trading day at $160.95, achieving a market capitalization of over $2.1 trillion, reflecting robust investor confidence and providing a solid market validation for blockchain exchanges.
- Increased Pressure on Traditional Finance: With Kalshi's approval to trade bitcoin perps, traditional exchanges like CME and Nasdaq face pressure to adapt to rapidly evolving investment products and asset classes to maintain market competitiveness.
- Recognition of Blockchain Technology: Hyperliquid's tradeable token has surged over 150% this year, indicating the growing prominence of blockchain in mainstream finance, serving as a powerful tool against traditional finance and driving the long-term development of digital assets.
See More
